Patient satisfaction with an injection device for multiple sclerosis treatment
Authors:
- 25 January 2006
- journal article
- clinical trial
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 113 (3) , 156-162
Abstract
Objectives – To develop a measure of treatment satisfaction assessing attributes specific to injected interferon‐beta‐1a (IFN‐β‐1a) for multiple sclerosis (MS), and to test pain and instrument sensitivity to change among patients changing injection devices. Materials and methods – The MS Treatment Concerns Questionnaire (MSTCQ) was developed and tested with pain assessments before and 3 months after patients changed devices from Rebiject to Rebiject II. Results – The MSTCQ was organized with two domains: Injection System Satisfaction and Side Effects (three subscales: Injection Site Reactions, Global Satisfaction, and Flu‐Like Symptoms). Significant improvements (P = 0.002 to P < 0.001) occurred with the new injection device in all MSTCQ subscales (except Flu‐Like Symptoms), and all pain measures (P < 0.0001). Clinically meaningful improvement was demonstrated in all scales, except Flu‐Like Symptoms, by effect sizes (0.23–0.59). Conclusions – These statistically significant and clinically meaningful improvements in MSTCQ and pain measures show the value of technologically advanced devices in domains of concern to patients.Keywords
This publication has 21 references indexed in Scilit:
- Preference for insulin delivery systems among current insulin users and nonusersClinical Therapeutics, 2004
- Effect on quality of life with a new insulin injection device in elderly patients with diabetes mellitus type 2Journal of Diabetes and its Complications, 2004
- A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitusClinical Therapeutics, 2003
- Randomized, comparative study of interferon β-1a treatment regimens in MSNeurology, 2002
- Subcutaneous Injection Survey: Psychometric Evaluation of a Treatment Satisfaction Instrument Associated with a Novel HIV MedicationHIV Research & Clinical Practice, 2002
- Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and infection anxiety on adherence and ability to self-injectAnnals of Behavioral Medicine, 2001
- Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes.Diabetes Care, 2000
- Clinical Significance of Reported Changes in Pain Severity☆☆☆★Annals of Emergency Medicine, 1996
- Effect Sizes for Interpreting Changes in Health StatusMedical Care, 1989
- The short-form McGill pain questionnairePain, 1987